Kidney transplant after MPA: referral, donors and waiting
Every medical claim on this page links to its source. Last updated 15 November 2026. Educational information, not medical advice.
Referral and evaluation
Ask about referral when kidney failure is likely or dialysis has begun. The center reviews the cause of kidney failure, whether vasculitis is in remission, heart and general health, infection and cancer history, fitness for surgery, blood type, tissue and antibody testing, medicines, and whether follow-up and long-term prescriptions are accessible.1,2,3
Being referred, completing evaluation, and being active on the waitlist are separate steps.4
Living or deceased donor
A living donor is evaluated separately for medical suitability and voluntary consent. Paired donation may be possible if a willing donor is not a match. A deceased-donor transplant requires being accepted and listed. In the United States, adults who have not started dialysis may begin accruing waiting time once kidney function is at or below 20; your center confirms the current policy.1,3,4
While you wait
Confirm your listing status and contact details, keep up with dialysis and lab requirements, tell the center about illness, hospital stays or travel, and plan transport for when you are called.1,4
Surgery and early recovery
The new kidney is usually placed low in the belly and joined to blood vessels and the bladder; your own kidneys usually stay. Anti-rejection medicine starts around surgery. Early on, frequent labs check kidney function and medicine levels. Some kidneys start slowly and temporary dialysis may be needed; slow function has several causes that the team checks separately from MPA.1,5
Before leaving the hospital
- Get the medicine schedule in writing, including lab timing and what to do after a missed or vomited dose.
- Confirm who to call for fever, wound changes, low urine, persistent vomiting or diarrhea, sudden swelling, or trouble getting medicines.
- Ask when you can travel, exercise or return to work or school.6,1
Next: MPA timing and recurrence · hospital stay help
Sources
- NIDDK (NIH): Kidney transplant [doc ref 49]
- KDIGO: KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis [doc ref 1]
- HRSA / OPTN: OPTN policies [doc ref 50]
- American Kidney Fund: Guide to kidney transplant (2026) [doc ref 50]
- International Pediatric Transplant Association: Management of the paediatric kidney transplant recipient, 2026 [doc ref 8]
- American Society of Transplantation: Pediatric transition portal: managing my health [doc ref 2]
Links checked 15 November 2026. Full list: all sources.